| John Michael Sadaj, MD | |
|
215 E Hawaii Ave, Nampa, ID 83686-6011 | |
| (208) 463-3000 | |
| (208) 463-3044 |
| Full Name | John Michael Sadaj |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Location | 215 E Hawaii Ave, Nampa, Idaho |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407846140 | NPI | - | NPPES |
| 000010140225 | Other | ID | BLUE SHIELD |
| 290015068 | Other | ID | RAILROAD MEDICARE |
| 51573 | Other | ID | BLUE CROSS |
| 806441300 | Medicaid | ID |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | M8703 (Idaho) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| John Michael Sadaj, MD 215 E Hawaii Ave, Nampa, ID 83686-6011 Ph: (208) 463-3000 | John Michael Sadaj, MD 215 E Hawaii Ave, Nampa, ID 83686-6011 Ph: (208) 463-3000 |
News Archive
As hospitals look for ways to stem the opioid crisis, a survey of health-system pharmacy directors released today found that most large health systems have active stewardship programs to prevent the misuse of opioids - with pharmacists playing a key role in detecting drug diversion and identifying strategies to encourage appropriate opioid prescribing.
AbbVie today announced that it has entered into an exclusive worldwide license agreement with C2N Diagnostics, a privately held protein diagnostic and therapeutic discovery company, to develop and commercialize a portfolio of anti-tau antibodies for the treatment of Alzheimer's Disease and other neurological disorders.
Rexahn Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, announced today that it has signed an exclusive license agreement with the University of Maryland, Baltimore for a novel drug delivery platform, Nano-Polymer-Drug Conjugate Systems.
U.S. Environmental Protection Agency's Office of Research and Development has completed its review of a dioxin exposure study conducted by the University of Michigan in the Midland-Saginaw, Michigan area. EPA found the study was conducted well and provided useful, scientifically credible information. However, the study is of limited value to help EPA fully evaluate human exposure to levels of dioxin in the Tittabawassee River and Saginaw River and Bay.
› Verified 8 days ago
Wesley David Pidcock, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4400 E Flamingo Ave Ste 200, Nampa, ID 83687 Phone: 208-302-2100 Fax: 208-302-2125 | |
Kenneth Wilhelm Jr., Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 4400 E Flamingo Ave, Nampa, ID 83687 Phone: 208-288-4970 Fax: 208-288-4990 | |
Michael M Dee, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 215 E Hawaii Ave, Nampa, ID 83686 Phone: 208-463-3234 Fax: 208-463-3044 | |
Justin Tomal, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1200 Garrity Blvd, Nampa, ID 83687 Phone: 208-343-6458 | |
Braden Lawrence, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 85 S Middleton Rd, Nampa, ID 83651 Phone: 208-381-4100 | |
Ryan J. Williams, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 900 N Happy Valley Rd, Nampa, ID 83687 Phone: 208-401-9639 | |
Nicholas W. Hodgman, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4424 E Flamingo Ave, Ste 300, Nampa, ID 83687 Phone: 208-302-0200 Fax: 208-302-0255 |